Cleared Special

K190555 - PowerX Lipo System (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2019
Decision
57d
Days
Class 2
Risk

K190555 is an FDA 510(k) clearance for the PowerX Lipo System. Classified as System, Suction, Lipoplasty For Removal (product code QPB), Class II - Special Controls.

Submitted by Solta Medical (Bothell, US). The FDA issued a Cleared decision on May 1, 2019 after a review of 57 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.5040 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Solta Medical devices

Submission Details

510(k) Number K190555 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 2019
Decision Date May 01, 2019
Days to Decision 57 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
57d faster than avg
Panel avg: 114d · This submission: 57d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QPB System, Suction, Lipoplasty For Removal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.5040
Definition A Suction Lipoplasty System Is A Device Intended For The Removal Of Adipose Tissue For Purposes Of Aesthetic Body Contouring
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - QPB System, Suction, Lipoplasty For Removal

All 55
Devices cleared under the same product code (QPB) and FDA review panel - the closest regulatory comparables to K190555.
LSSA (NP-200)
K252495 · Newpong Co., Ltd. · Apr 2026
AYON Body Contouring System (AYON SYSTEM)
K244050 · Apyx Medical Corporation · May 2025
PAL 7020 Console
K244026 · Microaire Surgical Instruments, LLC · Apr 2025
PAL Aspiration System
K242804 · Microaire Surgical Instruments, LLC · Dec 2024
AirSculpt Body Contouring System (AIRS-1-SYS)
K241835 · Cellmyx · Nov 2024
Vitruvian Liposaber
K240188 · Black & Black Surgical, Inc. · Sep 2024